Healthcare

TOMI Secures Critical Ireland Market Approval, Strengthening SteraMist's Position Across the European Union

EU Biocidal Products Regulation (BPR) Mutual Recognition Extends SteraMist Authorization to a Rapidly Growing Key Life Sciences MarketFREDERICK, Md., Aug. 17, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, announced today that its Binary Ionization Technology has received formal approval in Ireland under the European Union's Biocidal Products Regulation (BPR), extending the Company's growing foo

Tomi Environmental Solutions, Inc.August 17, 20264 min read
TOMI Secures Critical Ireland Market Approval, Strengthening SteraMist's Position Across the European Union

About this update from Tomi Environmental Solutions, Inc.

EU Biocidal Products Regulation (BPR) Mutual Recognition Extends SteraMist Authorization to a Rapidly Growing Key Life Sciences Market FREDERICK, Md., Aug. 17, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® ("TOMI") (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, announced today that its Binary Ionization Technology has received formal approval in Ireland under the European Union's Biocidal Products Regulation (BPR), extending the Company's growing footprint of authorizations across the European Union. BIT Solution is now approved in Ireland in addition to 10 other European markets including: Austria, Italy, the Netherlands, Belgium, Denmark, Germany, Hungary, Spain, Great Britain and Northern Ireland.   The EU authorizations cover BIT Solution for both SteraMist room fogging and surface spraying equipment. The product is approved for professional indoor use, addressing bacteria, yeasts, and mycobacteria serving the medical, healthcare, industrial, commercial, hospitality, institutional, and tertiary sectors. "Ireland's approval reinforces SteraMist's position in a market that is home to some of the world's most demanding contamination-control and decontamination standards," said Dr. Halden Shane, CEO of TOMI Environmental Solutions. "As the region's life sciences and healthcare sectors continue to raise the bar on validated, documented efficacy, we believe iHP technology is well positioned to meet that demand and expand its footprint across the market." Ireland Life Sciences Addressable Market Ireland represents one of Europe's most concentrated life sciences and pharmaceutical manufacturing hubs and is also where one of TOMI's established decontamination and sterilization competitors is headquartered. Securing authorization in this market positions SteraMist and iHP technology alongside long-established players in a region where regulatory scrutiny and validation standards are among the most demanding in the world. According to IDA Ireland, Ireland ranks as the world's third-largest pharmaceutical exporter and is home to more than 90 pharmaceutical companies, including nine of the world's top 10 global pharmaceutical companies (Source: IDA Ireland). TOMI continues to see growing interest in SteraMist iHP decontamination from organizations expanding their contamination-control programs internationall...

View stock analysis, news, and events for Tomi Environmental Solutions, Inc.